Literature DB >> 30974484

Clinical approach to prostatic diseases in the dog.

Marco Cunto1, Elisa Mariani1, Eleonora Anicito Guido1, Giulia Ballotta1, Daniele Zambelli1.   

Abstract

In small animal practice, prostatic diseases are increasingly encountered. All dogs may experience prostatic disease, but particular care should be addressed to breeding dogs, in which prostatic affection may lead to decrease in semen quality and fertility. The most common prostatic disease is the benign prostatic hyperplasia (BPH) followed by prostatitis, prostatic neoplasia and prostate squamous metaplasia. These diseases do not have pathognomonic symptoms, therefore, making a correct diagnosis may not be easy. An accurate clinical examination and a correct diagnostic protocol are essential in order to begin the most appropriate treatment, and also to do a good prophylaxis where it is possible. BPH therapy is usually recommended when mild-severe signs are present or if symptoms disturb the patient. New therapeutic approaches, both medical and surgical, allow to maintain fertility in most animals with prostatic disorders. Prostate cancer is relatively infrequent. Elective therapy is the surgical one, but it is considered palliative and can result in important post-operative complications. The aim of this paper is to lay down the most appropriate diagnostic process describing the aetiologies of prostatic disease, their symptoms, the right investigative tools and therapy.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  diagnosis; dog; prostate; prostatic diseases; therapy

Mesh:

Year:  2019        PMID: 30974484     DOI: 10.1111/rda.13437

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  7 in total

1.  Does finasteride treatment for benign prostatic hyperplasia influence sperm DNA integrity in dogs?

Authors:  Daniel S R Angrimani; Luana C Bicudo; Nuria Llamas Luceño; Bruno R Rui; Matheus F Silva; João D A Losano; Bart Leemans; Ann Van Soom; Camila I Vannucchi
Journal:  Basic Clin Androl       Date:  2020-07-16

2.  Reproductive and endocrinological effects of Benign Prostatic Hyperplasia and finasteride therapy in dogs.

Authors:  Daniel S R Angrimani; Maíra M Brito; Bruno R Rui; Marcílio Nichi; Camila I Vannucchi
Journal:  Sci Rep       Date:  2020-09-09       Impact factor: 4.379

3.  Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines.

Authors:  Jan Torben Schille; Ingo Nolte; Eva-Maria Packeiser; Laura Wiesner; Jens Ingo Hein; Franziska Weiner; Xiao-Feng Wu; Matthias Beller; Christian Junghanss; Hugo Murua Escobar
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

Review 4.  Highlights on the Canine Prostatic Specific Esterase (CPSE): A diagnostic and screening tool in veterinary andrology.

Authors:  Monica Melandri; Salvatore Alonge
Journal:  Vet Med Sci       Date:  2020-09-02

Review 5.  Prostatectomy as a treatment for canine prostate cancer: a literature review.

Authors:  Jelle Stans
Journal:  Open Vet J       Date:  2020-09-21

6.  The anti-inflammatory properties of the methanolic extract of Cucumis melo Linn. against prostate enlargement in Wistar rats.

Authors:  R S Rajasree; Sibi P Ittiyavirah; Punnoth Poonkuzhi Naseef; Mohamed Saheer Kuruniyan; Muhammed Elayadeth-Meethal; S Sankar
Journal:  Saudi J Biol Sci       Date:  2022-07-25       Impact factor: 4.052

7.  Fibronectin Modulates the Expression of miRNAs in Prostate Cancer Cell Lines.

Authors:  Bruno Martinucci; Maira Smaniotto Cucielo; Brenda Carvalho Minatel; Sarah Santiloni Cury; Gabriel Henrique Caxali; Mirian Carolini Esgoti Aal; Sergio Luis Felisbino; Danillo Pinhal; Robson Francisco Carvalho; Flávia Karina Delella
Journal:  Front Vet Sci       Date:  2022-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.